FOLLOW IT
10 Dec 2020
Trial Summary
Clinical validation of circulating tumour DNA (ctDNA) mutation analysis by targeted NGS testing using FOLLOW IT in patients with solid tumours
Acronym:
FOLLOW-IT
ACTRN/NCT /ethics:
Scientific title:
Clinical validation of circulating tumour DNA (ctDNA) mutation analysis by targeted NGS testing using FOLLOW IT in patients with solid tumours
Sponsor / Cooperative group:
Sonic Genetics
Trial & Patient Characteristics
| Cancer Type | All cancers |
|---|---|
| Trial Type | Treatment |
| Phase | All phases |
| Age Range | 18 years and older |
| Sex | Both |
| Tumour Stream | Solid Tumors |
| Cancer Stage | - |
| Anticipated Start Date | - |
| Anticipated End Date | - |
Participating Hospitals
| Hospital | Ashford Cancer Centre Research |
|---|---|
| Clinical Trial Coordinator | Sue Yeend |
| syeend@adelaidecancercentre.com.au | |
| Phone | 08 8292 2240 |
| Principal Investigator | Dr Caroline Bampton |
| Recruitment Status | Recruiting |